Unlock Native & Engineered Exosomes with Improved Targeting, Optimize Analytics & Achieve Large-Scale Manufacturing for Effective Translation into the Clinic & Towards Commercialization

Uniting Key Biopharma and Academics Dedicated to Successfully Developing Exosome-Based Therapeutics

Building on the success of the 2022 summit, the 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications.

This year features a brand-new focus day on analytical development, diving into characterization assays, purification, and potency assays to enable robust translation into the clinic.

This is the most comprehensive, end-to-end meeting for industry personnel who are looking to fine-tune molecular components of exosomes, achieve GMP manufacturing of EVs for clinical applications, and successfully deliver payloads to the target tissue by evaluating route of administration to accelerate candidates towards commercialization.

What to expect:

32726 5th Exosome Based Therapeutics Summit logo favicon

3 days of carefully curated content

32726 5th Exosome Based Therapeutics Summit logo favicon

2 tracks of content covering preclinical & discovery aspects alongside a track dedicated to clinical development and manufacturing

32726 5th Exosome Based Therapeutics Summit logo favicon

140+ attendees from all stages of the R&D process

32726 5th Exosome Based Therapeutics Summit logo favicon

30 key speakers who are pioneering in the exosome field 

32726 5th Exosome Based Therapeutics Summit logo favicon

1 new pre-conference focus day diving into analytical development and characterization  

Join 140+ of your peers from a growing landscape covering all stages of R&D, including Discovery, Preclinical, Clinical, Manufacturing, and Analytics. Don’t miss out on joining the industry leaders to benchmark your progress, hear data-driven case studies, and take advantage of the networking opportunities throughout the 3 days to fast-track exosome therapeutics and delivery through to commercialization.

Our 2023 World-Class Speaker Faculty

Alex Tendler

Chief Technology Officer

ExoProTher Medical

Atta Behfar



Brittany Mihelich

Senior Scientist


Kuniko Kadoya

Director, Biological Research


Hear from our 2023 speakers

Alex Tendler, Chief Technology Officer, ExoProTher Medical

“Very interesting and valuable to get the perspective of other teams working with EVs in different therapeutic and diagnostic fields. I believe that such knowledge sharing will make a positive impact on all participants. Another important avenue is a possibility of a fruitful connection between developers and service providers in the field


Netta Blondheim-Shraga, Vice President, Research & Development, Brainstorm Cell Therapeutics

“This meeting brings together colleagues and thought leaders that specialize in this unique field and is, therefore, a great opportunity to network and share our scientific advances

Katie Gillian, Head of Research & Development, OmniSpirant

“I think it is incredibly valuable to take part in this
meeting to increase the knowledge and potential of the clinical application of EVs. The field is growing rapidly and the translation from bench to bedside needs to be performed to the highest standard” 

To read more reviews about the Exosomes Based Therapeutic Development Summit, head to our testimonials page and hear directly from our previous speakers about their experience.

Proud to Partner With

lonza logo
RoosterBio Sponsor Logo
newlogo jpeg (002)
NIS Color Logo with Tagline
Other Events in the World RNA Series: